IVERIC bio (FRA:O2T) Marketable Securities : €123.61 Mil (As of Mar. 2023)

View and export this data going back to 2013. Start your Free Trial

What is IVERIC bio Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. IVERIC bio's Marketable Securities for the quarter that ended in Mar. 2023 was €123.61 Mil.

IVERIC bio's annual Marketable Securities declined from Dec. 2020 (€118.10 Mil) to Dec. 2021 (€106.47 Mil) but then increased from Dec. 2021 (€106.47 Mil) to Dec. 2022 (€160.98 Mil).

IVERIC bio Marketable Securities Historical Data

The historical data trend for IVERIC bio's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVERIC bio Marketable Securities Chart

IVERIC bio Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

118.10

106.47

160.98

IVERIC bio Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Marketable Securities	Get a 7-Day Free Trial															139.65	161.62	169.11	160.98	123.61

IVERIC bio Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

IVERIC bio (FRA:O2T) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

IVERIC bio Marketable Securities Related Terms

Thank you for viewing the detailed overview of IVERIC bio's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

IVERIC bio (FRA:O2T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IVERIC bio Inc (FRA:O2T) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Sylvan Way, Parsippany, New Jersey, USA, 07054

Website

https://www.ivericbio.com

IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

IVERIC bio (FRA:O2T) Headlines

No Headlines